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Receptor/
Family* Symbols Ligands Major Functions
Disease 
Associations Target Genes
Estrogen 
receptors*
ERα/NR3A1; 
ERβ/NR3A2
Endogenous: 17β-estradiol Regulation of cell growth and proliferation 
in multiple tissues (e.g., female reproductive 
tissues, bone, and CNS)
Cancer, cardiovascular, 
immune and 
inflammatory, 
metabolic, neurological, 
reproductive
↑ MYC, NGF, BCL2, CXCL2, 
IGF1, TYMS; ↓ CD36, NDRG1, 
NCOR1, NCOA3Clinical: Mixed agonists (e.g. tamoxifen, 
raloxifene, and toremifene in breast cancer)
Xenobiotics: Bisphenol A, PCBs
Androgen 
receptor
AR/NR3C4 Endogenous: Testosterone, 
dihydrotestosterone
Key role in male reproductive organs in 
addition to other systems (e.g., CNS)
Cancer, cardiovascular, 
immune, metabolic, 
neurological, 
reproductive
↑ MYC, VEGF, BCL2, IGF1, 
MUC1, P66(Shc), CCND1; 
↓ TSHA, TSHB, PTEN, FAS, 
CASP2, CTNND2, ESR2, 
TMPRSS2
Clinical: Flutamide and bicalutamide for 
prostate cancer and alopecia
Glucocorticoid 
receptor
GR/NR3C1 Endogenous: Cortisol (hydrocortisone) Diverse developmental and physiological 
roles (e.g., antagonism of inflammatory 
signaling pathways, mediation of the stress 
response, and gluconeogenesis)
Metabolic, 
cardiovascular, immune 
and inflammatory, 
memory
↑ SCNN1A, GADD45B, GILZ, 
TAT; ↓ BGLAP, POMC, INS
Clinical: Fluticasone and prednisolonein 
inflammatory disorders
Vitamin D 
receptor
VDR/NR1I1 Endogenous: Calcitriol (1′,25′ dihdroxy 
vitamin D3)
Maintenance of serum calcium and 
phosphate levels for skeletal integrity; 
antiproliferative in many tissues
Bone, cancer, 
cardiovascular, 
metabolic, immune and 
inflammatory, renal, 
neurological
↑ FGF23, CYP24A1, CALB1, 
BGLAP, SPP1; ↓ IL2, PHEX
Clinical: Paracalcitol for 2o 
hyperparathyroidism in renal patients; 
Tacalcitol for psoriasis
Thyroid hormone 
receptors*
TRα/NR1A1; 
TRβ/NR1A2
Endogenous: Thyroxine 
(T4),Triiodothyronine (T3)
Regulation of oxygen consumption; protein, 
carbohydrate, lipid, and vitamin metabolism
Thyroid conditions, 
cancer
↑ ADRB1, PCK2, GH1, UCP1; ↓ 
DIO2, EHHADH, PRL, EGFR
Clinical: Levo-thyroxine, triiodothyroacetic 
acid (TRIAC) in resistance to thyroid 
hormone
Progesterone 
receptor
PR/NR3C3 Endogenous: Progesterone Diverse reproductive functions (e.g., 
establishing and maintaining pregnancy, 
developing breast tissue, and stopping 
proliferation in the uterus)
Cancer, metabolic, 
reproductive
↑ SERPINB14, FAS, MT2A, 
PGC, EGFR , IHH; ↓ ESR1, PGR, 
ANXA6Clinical: RU486 (Mifepristone) as an 
abortifacient
Mineralocorticoid 
receptor
MR/NR3C2 Endogenous: Aldosterone Regulating electrolyte and fluid balance in 
the kidney; specific roles in the CNS
Metabolic ↑ SCNN1A, ATP1A1, ATP1B1, 
GILZ, SGK1, NDRG2
Clinical: Spironolactone in hypertensive 
cardiovascular disease
Peroxisome-
proliferator-
activated 
receptor-γ 
PPARγ/NR1C3 Endogenous: FAs and FA intermediates Regulation of adipocytes, insulin sensitivity 
and lipogenesis, and broader integration of 
energy, lipid, and carbohydrate metabolism
Cardiovascular, 
metabolic, cancer, 
neurological
↑ FABP4, UCP1, AP2, PCK1, 
LPL, ADIPOQ, CD36, AQP7
Dietary: FAs and PUFAs
Clinical: Thiazolidinediones (e.g., 
rosiglitazone) in type II diabetes 
Peroxisome-
proliferator-
activated 
receptor-α
PPARα/
NR1C1
Endogenous: FAs and FA intermediates Regulating energy expenditure; modulating 
fatty acid oxidation systems (mitochondria), 
peroxisome β-oxidation, and microsomal 
ω-oxidation
Cardiovascular, 
metabolic, cancer, 
neurological
↑ ACBP, ACOX1, APOA1, 
CPT1A, CYP1A1, CYP4A1, 
CYP7A1, SLC27A1, LCAS, 
MLYCD, SCD, FADS2, RETN, 
MYC, CCND1, IGFBP1, UCP1, 
KRT23, IL6, TF, PEX11A
Clinical: Fibrates (e.g., fenofibrate) in 
hyperlipidemia 
Dietary: FAs and PUFAs
Xenobiotics: DEHP, DEHA
Peroxisome-
proliferator-
activated 
receptor-δ (β)
PPARδ/
NR1C2
Endogenous: FAs and FA intermediates Regulating cell proliferation, differentiation, 
and migration in wound healing and 
inflammatory processes
Cardiovascular, 
metabolic, cancer, 
neurological
↑ ACSL3, CPT1A, RGS3, RGS4, 
RGS5, ISG20, CXCL7, CCL21, 
RETN, CPT1ADietary: FAs and PUFAs
Retinoic acid 
receptors*
RARα/NR1B1; 
RARβ/NR1B2; 
RARγ/NR1B3
Endogenous: All-trans and 9-cis retinoic 
acid
Pleiotropic control of embryonic patterning 
and organogenesis, cell proliferation, 
differentiation, apoptosis and homeostatic 
control
Neurological and 
psychiatric, cancer
↑ Numerous HOX genes, STRA6, 
HNF3A, CRABP2, ACADM, 
MECOM; ↓ CYP1A1, HOXB9
Clinical: Tretinoin for treating acne and 
acute promyelocytic leukemia
Liver X receptors* LXRα/NR1H3; 
LXRβ/NR1H2
Endogenous: Oxysterols Cholesterol and steroid sensors with roles in 
lipid and carbohydrate metabolism
Metabolic ↑ SREBP1C, CYP7A1, ABC8, 
APOA1, APOE, LPL, PLTP
Retinoid X 
receptors*
RXRα/NR2B1; 
RXRβ/NR2B2; 
RXRγ/NR2B3
Endogenous: 9-cis retinoic acid Embryonic cell patterning and 
organogenesis, cell proliferation and 
differentiation, other functions as 
heterodimers with other nuclear receptors
Neurological and 
psychiatric, immune
↑↓ many genes as heterodimers 
with other receptors (e.g.,LXRs, 
PPARs, FXR, TRs, RARs; ↑ ABC1 
(with LXR); ↓ CYP7A1 (with FXR)
Pregnane X 
receptor
PXR/NR1I2 Endogenous: Bile acids Metabolism and transport of pharmaceutical 
drugs, xenobiotics, and toxic bile acids in 
the liver and GI tract
Immune ↑ Multiple CYP2 and CYP3 
gene family members, MDR1, 
MRP2, OATP2, UGT1A1, SULT, 
↓ CYP7A1
Xenobiotic: St. John’s Wort (hyperforin), 
Taxol, rifampicin, phenobarbital
Dietary: Vitamin E, sulforaphane, Gugulipid
Constitutive 
androstane 
receptor
CAR/NR1I3 Endogenous: Androstanol, androstenol Metabolism of xenobiotics and endogenous 
lipids by regulating expression of 
cytochrome P450 genes
Involved in 
hepatotoxicity of 
acetaminophen
↑ CYP2B10, CYP311A, CYP3A4, 
CYP1A2, CYP2B6 THRSP, 
SLC21A6, MRP2, MDR1, OATP2Xenobiotics: Phenobarbital, DEHP, 
Meclizine
Farnesoid X 
receptor
FXR/NR1H4 Endogenous: Bile acids (e.g., 
chenodeoxycholic acid)
A sensor for bile acid that helps regulate bile 
acid homeostasis
Metabolic ↑ SLC10A2, ABCB1, ABCB11, 
NR0B2, HSD3B2, FETUB, 
ABCB4, FGF19, NOS2; ↓ 
CYP7A1, HNF1A, HNF4A, 
SLCO1B1, SLC10A2
Dietary: Cafestol, guggulsterone
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Nuclear receptors (NRs) are a superfamily of transcription factors regulated by the direct binding of endogenous, dietary, clinical, and xenobiotic ligands. NRs are defined by the 
presence of conserved zinc finger DNA- and/or ligand-binding regions. NRs interact with a group of diverse factors named coregulators (i.e., coactivators and corepressors) to 
orchestrate programs of gene expression in specific tissues. Cell signaling pathways also can regulate NRs and their coregulators.
In this SnapShot, we present information on the endocrine nuclear receptors and the adopted orphan receptors. The endocrine receptors are activated by small and predomi-
nantly lipophilic ligands of the endocrine system, many of which have well known physiological roles. This subgroup consists of the first seven receptors in the chart: the estrogen 
(ER), androgen (AR), glucocorticoid (GR), vitamin D (VDR), thyroid (TR), progesterone (PR), and mineralocorticoid (MR) receptors. Adopted orphan receptors are a subgroup 
for which cognate ligands were uncharacterized at the time of their cDNA cloning but have since been identified. This group includes the last fourteen receptors in the chart: 
peroxisome-proliferator-activated (PPAR), retinoic acid (RAR), liver X (LXR), retinoic X (RXR), pregnane X(PXR), constitutive androstane (CAR), and farnesoid X (FXR) receptors. 
The ordering in the table is based on visits to the Nuclear Receptor Signaling Atlas (NURSA) Molecule Pages from May 2009 to May 2010.
The table includes information about NR ligands, target genes, functions, and disease associations. Although human gene names are shown (familiar name/Nuclear Receptor 
Nomenclature Committee name), regulation may have been demonstrated in human, mouse, or rat cells or tissues. In certain cases, subfamily members that are encoded by 
distinct genes are discussed collectively. However, each receptor has specific contributions to the endocrine signaling axis in question. Additional information, such as expres-
sion, knockout phenotypes, transcriptomics, cistromics, proteomics, and specific references for disease associations, is available at the NURSA Molecule Pages (http://www.
nursa.org) and in the selected further reading provided below.
Abbreviations
CNS, central nervous system; DEHA, Bis(2-ethylhexyl) adipate; DEHP, Bis(2-ethylhexyl) phthalate; GI, gastrointestinal; FAs, fatty acids; PCBs, polychlorinated biphenyls; PUFAs, 
polyunsaturated fatty acids.
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